OVERVIEW OF THE COVID-19 PANDEMIC AND ITS IMPACT ON THE MORBIDITY IN THE SOFIA CITY REGION DURING 2020-2021
DOI:
https://doi.org/10.58395/pipd.v50i2.91Abstract
The COVID-19 pandemic that began in early 2020 is associated with high global morbidity and mortality and represents a considerable burden on the national health systems, the economy, and society as a whole.
This article presents the main epidemiological indicators characterizing the spread of COVID-19 in the Sofia City region: incidence, mortality, and case fatality rate. The age and monthly distribution of incidence and mortality, COVID-19-related admissions to healthcare facilities, and COVID-19 cases among healthcare professionals are described. The activities of Sofia City Regional Health Inspectorate, which was at the front line in efforts to limit the spread of the pandemic coronavirus, are reviewed.
Downloads
References
Ghebreyesus TA. WHO Director-General’s opening remarks at the media briefing on COVID-19—11 March 2020.
World Health Organization. Coronavirus (COVID-19) Dashboard. https://covid19.who.int/
Hoffmann C, Wolf E. Older age groups and country-specific case fatality rates of COVID-19 in Europe, USA, and Canada. Infection. 2021. 49:111–116. doi: https://doi.org/10.1007/s15010-020-01538-w DOI: https://doi.org/10.1007/s15010-020-01538-w
Lechien JR, Chiesa-Estomba CM, Place S, Laethem YV, et al. Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019. J Intern Med, 2020;288:335-344. doi: https://doi.org/10.1111/joim.13089 DOI: https://doi.org/10.1111/joim.13089
Stokes EK, Zambrano LD, Anderson KN, Marder EP, et al. Coronavirus Disease 2019 Case Surveillance - United States, January 22-May 30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(24):759-765. doi: https://doi.org/10.15585/mmwr.mm6924e2 DOI: https://doi.org/10.15585/mmwr.mm6924e2
Li X, Xu S, Yu M, Wang K, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol 2020;146(1):110-118. doi: https://doi.org/10.1016/j.jaci.2020.04.006 DOI: https://doi.org/10.1016/j.jaci.2020.04.006
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. d oi: https://doi.org/10.1016/S0140-6736(20)30183-5 DOI: https://doi.org/10.1016/S0140-6736(20)30183-5
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708–20.doi: https://doi.org/10.1056/NEJMoa2002032 DOI: https://doi.org/10.1056/NEJMoa2002032
Wu JT, Leung K, Bushman M. Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China. Nat Med. 2020;26:506–10. doi: https://doi.org/10.1038/s41591-020-0822-7 DOI: https://doi.org/10.1038/s41591-020-0822-7
Yang W, Kandula S, Huynh M, Greene SK, et al. Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: a model-based analysis. ancet Infect Dis. 2021;21(2):203–212. doi: https://doi.org/10.1016/S1473-3099(20)30769-6 DOI: https://doi.org/10.1016/S1473-3099(20)30769-6
Wolff D, Nee S, Hickey NS, Marschollek M. Risk factors for Covid-19 severity and fatality: a structured literature review. Infection. 2021;49(1):15-28. doi: https://doi.org/10.1007/s15010-020-01509-1 DOI: https://doi.org/10.1007/s15010-020-01509-1
Schönfeld D, Arias S, Bossio JC, Fernández H, et al. Clinical presentation and outcomes of the first patients with COVID-19 in Argentina: Results of 207079 cases from a national database. PLoS One. 2021;16(2):e0246793. doi: https://doi.org/10.1371/journal.pone.0246793 DOI: https://doi.org/10.1371/journal.pone.0246793
Ortiz-Prado E, Simbaña-Rivera K, Gómez-Barreno L, Rubio-Neira M, et al. Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review. Diagn Microbiol Infect Dis. 2020;98(1):115094. doi: https://doi.org/10.1016/j.diagmicrobio.2020.115094 DOI: https://doi.org/10.1016/j.diagmicrobio.2020.115094
Rudberg A-S, Havervall S, Månberg A, Falk AJ, et al . SARS-CoV-2 exposure, symptoms, and seroprevalence in healthcare workers in Sweden. Nat Commun. 2020;11(1):5064. doi: https://doi.org/10.1038/s41467-020-18848-0 DOI: https://doi.org/10.1038/s41467-020-18848-0
Kluytmans-van den Bergh MFQ, Buiting AGM, Pas SD, Bentvelsen R, et al. Prevalence and clinical presentation of health care workers with symptoms of coronavirus disease 2019 in 2 Dutch Hospitals during an early phase of the pandemic. JAMA Netw Open. 2020;3(5):e209673. doi: https://doi.org/10.1001/jamanetworkopen.2020.9673 DOI: https://doi.org/10.1001/jamanetworkopen.2020.9673
Buonafine CP, Piatto BNM, Leal FB, de Matos SF, et al. High prevalence of SARS-CoV-2 infection among symptomatic healthcare workers in a large university tertiary hospital in São Paulo, Brazil. BMC Infect Dis. 2020; 20: 917. doi: https://doi.org/10.1186/s12879-020-05662-8 DOI: https://doi.org/10.1186/s12879-020-05662-8
Dzinamarira T, Murewanhema G, Mhango M, Iradukunda PG, et al. COVID-19 prevalence among healthcare workers. A systematic review and meta-analysis. Int J Environ Res Public Health 2022;19:146. doi: https://doi.org/10.3390/ijerph19010146 DOI: https://doi.org/10.3390/ijerph19010146
Antonio-Villa NE, Bello-Chavolla OY, Vargas-Vázquez A, Carlos A Fermín-Martínez CA, et al . Assessing the Burden of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers in Mexico City: A Data-Driven Call to Action. Clin Infect Dis. 2021;73(1):e191-e198. doi: https://doi.org/10.1093/cid/ciaa1487 DOI: https://doi.org/10.1093/cid/ciaa1487
Liu C-W, Jeyakumar N, McArthur E, Sontrop JM, et al. SARS-CoV-2 testing, infection and outcomes among Ontario physicians: a descriptive population-based cohort study. CMAJ Open. 2022;10(3):E657-E665. doi: https://doi.org/10.9778/cmajo.20210263 DOI: https://doi.org/10.9778/cmajo.20210263
Haas EJ, Angulo FJ, McLaughlin JM, Anis E, Singer SR, Khan F, et al. Nationwide vaccination campaign with BNT162b2 in Israel demonstrates high vaccine effectiveness and marked declines in the incidence of SARS-CoV-2 infections and COVID-19 cases, hospitalizations, and deaths. SSRN. 2021. Available from: https://ssrn.com/abstract=3811387 (Preprint)
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Lilly Marinova (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
